PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490308
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490308
Precision Medicine Market, By Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Precision Medicine Market size was valued at USD 30,154.2 Million in 2023, expanding at a CAGR of 12.40% from 2024 to 2032.
Precision medicine, also known as personalized medicine or individualized medicine, is a method of healthcare that considers individual differences in genes, environment, and lifestyle when developing medical treatment plans and actions. Rather of taking a one-size-fits-all strategy, precision medicine seeks to personalize medical decisions and treatments to the unique characteristics of each patient.
Precision Medicine Market- Market Dynamics
Precision Medicine Utilizes Genetics and Proteins for Personalized Treatments, Driving Market Growth
Precision medicine uses the patient's genes and proteins to create a personalized treatment specifically tailored to treat their specific disease. Due to key findings like single nucleotide polymorphism and microarray/biochips in the realm of precision medicine, the market is anticipated to see significant growth in the near future. Studying the human genome is crucial for the advancement of precision medicine and has the ability to revolutionize medical care for each patient by analyzing their genetics, molecular makeup, and clinical features to provide tailored treatments for curing diseases. The mentioned factors are expected to boost the demand for precision medicine in the coming years. In addition, an increase in cancer cases is projected to drive the need for precision medicine for individualized treatments and testing, positively impacting market expansion. In the United States in 2018, close to 1.7 Million new cancer cases were diagnosed.
Precision Medicine Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.40% over the forecast period (2024-2032)
Based on Type segmentation, Inhibitor drugs was predicted to show maximum market share in the year 2023
Based on Indication segmentation, Oncology was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Precision Medicine Market- Segmentation Analysis:
The Global Precision Medicine Market is segmented on the basis of Type, Indication, End User, and Region.
The market is divided into three categories based on Type: Inhibitor drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs and Other Therapeutic Products. In 2023, the inhibitor drugs category accounted for the biggest share of the market due to factors such as increased effectiveness of inhibitor pharmaceuticals and a significant number of commercially approved drugs. Furthermore, inhibitor medications cover a wide range of indications, including oncology and uncommon illnesses.
The market is divided into two categories based on Indication: Oncology, Rare Diseases, Infectious diseases, Hematological disorders, and Other indications. The oncology category dominated the market from 2023 to 2032. Precision oncology is a rapidly emerging and promising research subject that allows for individualized therapy based on an individual's molecular and genetic traits. However, the central nervous system is the fastest-growing category over the predicted period, owing to the increased availability of precision medicine. The central nervous system Targeted Agent Prediction (CNS TAP) System was developed to help in the selection of precision medicine therapies based on patient-specific genomic data.
Precision Medicine Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. In terms of revenue, North America is the largest market share holding region in 2023 and is expected to continue its position in the future years. The increasing frequency of cancer, as well as the presence of prominent market players in the region, are projected to be key drivers driving market expansion in the region. Furthermore, demand for precision medicine is being driven mostly by positive government initiatives and increased investment in creating novel solutions for optimal illness management.
The Asia-Pacific precision medicine market is predicted to develop at the quickest CAGR between 2023 and 2032. This is owing to the availability of low-cost clinical trials for cutting-edge precision medicine, as well as significant investments in healthcare facilities and technology. Furthermore, the Chinese precision medicine industry had the biggest market share, while India's precision medicine market was the fastest-growing in the Asia-Pacific region.
Precision Medicine Market- Competitive Landscape:
Major market players are investing heavily in research and development to extend their product lines, which will help the precision medicine market grow even more. Market participants are also pursuing strategic measures to expand their global footprint, including new product launches, mergers and acquisitions, contractual agreements, higher investments, and collaboration with other businesses. Precision medicine competitors must provide cost-effective products in order to expand and survive in an increasingly competitive and rising market environment.
Recent Developments:
In January 2022, AstraZeneca and Scorpion Therapeutics have agreed to collaborate on the development, marketing, and discovery of precision therapies targeting hitherto difficult-to-target cancer proteins. It could transform oncology treatment by overcoming the challenges of targeting transcription factors and reaching underserved patient populations. It focuses on proteins known as transcription factors, which regulate important physiological processes and gene expression.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PRECISION MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Hoffmann-La Roche Ltd. (Switzerland)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Bristol Myers Squibb (US)
AstraZeneca (UK)
Gilead Sciences, Inc. (US)
AbbVie Inc. (US)
Eli Lilly and Company (US)
GlaxoSmithKline plc (UK)
Sanofi (France)
Johnson & Johnson (US)
Merck KGaA (Germany)
Amgen, Inc. (US)
Others
GLOBAL PRECISION MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Inhibitor drugs
- Monoclonal Antibodies
- Cell & Gene Therapy
- Antiviral & Anti-retroviral drugs
- Other Therapeutic Products
GLOBAL PRECISION MEDICINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Rare Diseases
- Infectious diseases
- Hematological disorders
- Other indications
GLOBAL PRECISION MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals and Clinics
- Home care settings
GLOBAL PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1.Precision Medicine Market Overview
- 1.1.Study Scope
- 1.2.Market Estimation Years
2.Executive Summary
- 2.1.Market Snippet
- 2.1.1.Precision Medicine Market Snippet by Type
- 2.1.2.Precision Medicine Market Snippet by Indication
- 2.1.3.Precision Medicine Market Snippet by End User
- 2.1.4.Precision Medicine Market Snippet by Country
- 2.1.5.Precision Medicine Market Snippet by Region
- 2.2.Competitive Insights
3.Precision Medicine Key Market Trends
- 3.1.Precision Medicine Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
- 3.2.Precision Medicine Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
- 3.3.Precision Medicine Market Opportunities
- 3.4.Precision Medicine Market Future Trends
4.Precision Medicine Industry Study
- 4.1.PEST Analysis
- 4.2.Porter's Five Forces Analysis
- 4.3.Growth Prospect Mapping
- 4.4.Regulatory Framework Analysis
5.Precision Medicine Market: COVID-19 Impact Analysis
- 5.1.Pre-COVID-19 Impact Analysis
- 5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments
6.Precision Medicine Market Landscape
- 6.1.Precision Medicine Market Share Analysis, 2023
- 6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis
7.Precision Medicine Market - By Type
- 7.1.Overview
- 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2.Inhibitor drugs
- 7.1.3.Monoclonal Antibodies
- 7.1.4.Cell & Gene Therapy
- 7.1.5.Antiviral & Anti-retroviral drugs
- 7.1.6.Other Therapeutic Products
8.Precision Medicine Market - By Indication
- 8.1.Overview
- 8.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 8.1.2.Oncology
- 8.1.3.Rare Diseases
- 8.1.4.Infectious diseases
- 8.1.5.Hematological disorders
- 8.1.6.Other indications
9.Precision Medicine Market - By End User
- 9.1.Overview
- 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
- 9.1.2.Hospitals and Clinics
- 9.1.3.Home care settings
10.Precision Medicine Market- By Geography
- 10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2.North America
- 10.2.1.Overview
- 10.2.2.Precision Medicine Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
- 10.2.7.1.Overview
- 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.7.4.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.7.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
- 10.2.8.1.Overview
- 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.8.4.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.8.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.Europe
- 10.3.1.Overview
- 10.3.2.Precision Medicine Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
- 10.3.7.1.Overview
- 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.7.4.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.7.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
- 10.3.8.1.Overview
- 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.8.4.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.8.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
- 10.3.9.1.Overview
- 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.9.4.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.9.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10.France
- 10.3.10.1.Overview
- 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.10.4.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.10.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
- 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.11.3.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.11.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
- 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.12.3.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.12.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
- 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.13.3.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.13.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
- 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.14.3.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.14.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
- 10.3.15.1.Overview
- 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.15.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Precision Medicine Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7.India
- 10.4.7.1.Overview
- 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.7.4.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.7.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8.China
- 10.4.8.1.Overview
- 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.8.4.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.8.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
- 10.4.9.1.Overview
- 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.9.4.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.9.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
- 10.4.10.1.Overview
- 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.10.4.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.10.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
- 10.4.11.1.Overview
- 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.11.4.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.11.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
- 10.4.12.1.Overview
- 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.12.4.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.12.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
- 10.4.13.1.Overview
- 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.13.4.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.13.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
- 10.4.14.1.Overview
- 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.14.4.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.14.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
- 10.4.15.1.Overview
- 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.15.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Precision Medicine Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
- 10.5.7.1.Overview
- 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.7.4.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.7.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
- 10.5.8.1.Overview
- 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.8.4.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.8.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
- 10.5.9.1.Overview
- 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.9.4.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.9.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
- 10.5.10.1.Overview
- 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.10.4.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.10.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
- 10.5.11.1.Overview
- 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.11.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Precision Medicine Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
- 10.6.7.1.Overview
- 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.7.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
- 10.6.8.1.Overview
- 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.8.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
- 10.6.9.1.Overview
- 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.9.4.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.9.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
- 10.6.10.1.Overview
- 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.10.4.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.10.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
- 10.6.11.1.Overview
- 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.11.4.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.11.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
- 10.6.12.1.Overview
- 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.12.4.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.12.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
- 10.6.13.1.Overview
- 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.13.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.Key Vendor Analysis- Precision Medicine Industry
- 11.1.Competitive Dashboard
- 11.2.Company Profiles
- 11.2.1.Hoffmann-La Roche Ltd. (Switzerland)
- 11.2.2.Novartis AG (Switzerland)
- 11.2.3.Pfizer Inc. (US)
- 11.2.4.Bristol Myers Squibb (US)
- 11.2.5.AstraZeneca (UK)
- 11.2.6.Gilead Sciences, Inc. (US)
- 11.2.7.AbbVie Inc. (US)
- 11.2.8.Eli Lilly and Company (US)
- 11.2.9.GlaxoSmithKline plc (UK)
- 11.2.10.Sanofi (France)
- 11.2.11.Johnson & Johnson (US)
- 11.2.12.Merck KGaA (Germany)
- 11.2.13.Amgen, Inc. (US)
- 11.2.14.Others
12.360 Degree Analyst View
13.Appendix
- 13.1.Research Methodology
- 13.2.References
- 13.3.Abbreviations
- 13.4.Disclaimer
- 13.5.Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Precision Medicine Market: Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Precision Medicine Market, by Type 2019-2032 (USD Million)
- TABLE Precision Medicine Market: Indication Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Indication
- TABLE Global Precision Medicine Market, by Indication 2019-2032 (USD Million)
- TABLE Precision Medicine Market: End User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Precision Medicine Market, by End User 2019-2032 (USD Million)
- TABLE Precision Medicine Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Precision Medicine Market, by Region 2019-2032 (USD Million)
- TABLE North America Precision Medicine Market, by Country, 2019-2032 (USD Million)
- TABLE North America Precision Medicine Market, by Type, 2019-2032 (USD Million)
- TABLE North America Precision Medicine Market, by Indication, 2019-2032 (USD Million)
- TABLE North America Precision Medicine Market, by End User, 2019-2032 (USD Million)
- TABLE Europe Precision Medicine Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Precision Medicine Market, by Type, 2019-2032 (USD Million)
- TABLE Europe Precision Medicine Market, by Indication, 2019-2032 (USD Million)
- TABLE Europe Precision Medicine Market, by End User, 2019-2032 (USD Million)
- TABLE Asia Pacific Precision Medicine Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Precision Medicine Market, by Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Precision Medicine Market, by Indication, 2019-2032 (USD Million)
- TABLE Asia Pacific Precision Medicine Market, by End User, 2019-2032 (USD Million)
- TABLE Latin America Precision Medicine Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Precision Medicine Market, by Type, 2019-2032 (USD Million)
- TABLE Latin America Precision Medicine Market, by Indication, 2019-2032 (USD Million)
- TABLE Latin America Precision Medicine Market, by End User, 2019-2032 (USD Million)
- TABLE Middle East and Africa Precision Medicine Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Precision Medicine Market, by Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Precision Medicine Market, by Indication, 2019-2032 (USD Million)
- TABLE Middle East and Africa Precision Medicine Market, by End User, 2019-2032 (USD Million)
